Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) — Cash Flow Reinvestment Rate

Latest as of September 2025: 97.08x

Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Cash Flow Reinvestment Rate of 97.08x as of September 2025, reinvesting CN¥52.78 Million (capex CN¥52.78 Million ) from operating cash flow of CN¥543.69K. See Suzhou Zelgen Biopharmaceuticals Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

97.08x

(Capex + Investments) / Operating CF

Total Reinvested

CN¥52.78 Million

Capex + Investments

Operating Cash Flow

CN¥543.69K

CNY

Capital Expenditures

CN¥52.78 Million

CNY

Suzhou Zelgen Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Suzhou Zelgen Biopharmaceuticals Co Ltd across 1 annual periods. For the full cash flow conversion analysis, see 688266 cash generation efficiency.

Annual Cash Flow Reinvestment Rate for Suzhou Zelgen Biopharmaceuticals Co Ltd (2024–2024)

Year-by-year capital reinvestment analysis for Suzhou Zelgen Biopharmaceuticals Co Ltd. See how financially flexible is Suzhou Zelgen Biopharmaceuticals Co Ltd to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (CNY)	Operating CF	Capex	YoY Change
2024	48.30x	CN¥1.85 Billion	CN¥38.20 Million	CN¥95.69 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow